The LEADER cardiovascular outcomes trial demonstrated cardiovascular benefits, and subsequent analyses have shown reductions in inflammatory biomarkers
Schwab MA, Sauer SW, Okun JG, Nijtmans LG, Rodenburg RJ, van den Heuvel LP et al
"Biosynthesis of the pigments of life: formation of the macrocycle"
The treatments proven effectiveness in clinical trials must be weighed against personal factors such as cost, potential side effects , and the need for ongoing medical supervision
Di Pascuale MA, Espana EM, Liu DT, Kawakita T, Li W, Gao YY, Baradaran-Rafii A, Elizondo A, Raju VK, Tseng SC (2005) Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome
So it stimulates mTOR to build more muscle. Dr